Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antineoplastic agent prodrug |
| gptkbp:approvedBy |
gptkb:Japan
|
| gptkbp:ATCCode |
L01BC03
|
| gptkbp:CASNumber |
1972-08-3
|
| gptkbp:combines |
gptkb:gimeracil
gptkb:oteracil uracil |
| gptkbp:discoveredBy |
gptkb:Taiho_Pharmaceutical
|
| gptkbp:hasMolecularFormula |
C8H9FN2O3
|
| gptkbp:hasSMILES |
O=C1N(C(=O)NC1F)C2=CC=CC=C2
|
| https://www.w3.org/2000/01/rdf-schema#label |
tegafur
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
gptkb:5-fluorouracil
|
| gptkbp:prodrugOf |
gptkb:5-fluorouracil
|
| gptkbp:PubChem_CID |
5256
5456 CHEMBL1422 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea myelosuppression |
| gptkbp:UNII |
1W8R7QF6Y4
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:CYP2A6
|
| gptkbp:bfsLayer |
6
|